Integer Holdings Corp (ITGR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Integer Holdings Corp (ITGR) has a cash flow conversion efficiency ratio of 0.038x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($65.59 Million) by net assets ($1.75 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Integer Holdings Corp balance sheet quality to measure how much of total assets are equity-financed.
Integer Holdings Corp - Cash Flow Conversion Efficiency Trend (1999–2024)
This chart illustrates how Integer Holdings Corp's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of Integer Holdings Corp to evaluate the quality of earnings relative to operating cash generation.
Integer Holdings Corp Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Integer Holdings Corp ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Virbac SA
PA:VIRP
|
0.023x |
|
Henan Yuneng Holdings Co Ltd
SHE:001896
|
0.427x |
|
SINOPHARM GROUP 1/5/O.N.
F:X2S1
|
N/A |
|
AIR CHINA LTD H ADR/20
F:AD2B
|
N/A |
|
Alumis Inc
NASDAQ:ALMS
|
-0.239x |
|
China Wafer Level Csp Co Ltd
SHG:603005
|
0.031x |
|
Kyivstar Group Ltd. Common Shares
NASDAQ:KYIV
|
0.114x |
|
Zuger Kantonalbank
SW:ZUGER
|
0.345x |
Annual Cash Flow Conversion Efficiency for Integer Holdings Corp (1999–2024)
The table below shows the annual cash flow conversion efficiency of Integer Holdings Corp from 1999 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Integer Holdings Corp worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $1.62 Billion | $205.21 Million | 0.127x | +6.82% |
| 2023-12-31 | $1.52 Billion | $180.21 Million | 0.119x | +44.49% |
| 2022-12-31 | $1.42 Billion | $116.38 Million | 0.082x | -29.00% |
| 2021-12-31 | $1.35 Billion | $156.67 Million | 0.116x | -18.94% |
| 2020-12-31 | $1.27 Billion | $181.34 Million | 0.143x | -0.56% |
| 2019-12-31 | $1.15 Billion | $165.36 Million | 0.143x | -9.05% |
| 2018-12-31 | $1.06 Billion | $167.30 Million | 0.158x | -5.64% |
| 2017-12-31 | $893.38 Million | $149.36 Million | 0.167x | +14.89% |
| 2016-12-31 | $725.24 Million | $105.53 Million | 0.146x | +891.89% |
| 2015-12-31 | $850.62 Million | $12.48 Million | 0.015x | -88.91% |
| 2014-12-31 | $614.25 Million | $81.28 Million | 0.132x | +26.37% |
| 2013-12-31 | $542.05 Million | $56.76 Million | 0.105x | -22.34% |
| 2012-12-31 | $480.86 Million | $64.83 Million | 0.135x | -29.94% |
| 2011-12-31 | $467.28 Million | $89.92 Million | 0.192x | +6.83% |
| 2010-12-31 | $426.83 Million | $76.89 Million | 0.180x | -4.69% |
| 2009-12-31 | $379.72 Million | $71.77 Million | 0.189x | +24.35% |
| 2008-12-31 | $375.69 Million | $57.10 Million | 0.152x | +14.15% |
| 2007-12-31 | $322.67 Million | $42.97 Million | 0.133x | +1.79% |
| 2006-12-31 | $299.69 Million | $39.20 Million | 0.131x | -18.92% |
| 2005-12-31 | $268.61 Million | $43.34 Million | 0.161x | -7.87% |
| 2004-12-31 | $257.91 Million | $45.17 Million | 0.175x | -24.79% |
| 2003-12-31 | $235.34 Million | $54.80 Million | 0.233x | +73.21% |
| 2002-12-31 | $206.86 Million | $27.81 Million | 0.134x | +18.33% |
| 2001-12-31 | $188.84 Million | $21.45 Million | 0.114x | -15.02% |
| 2000-12-31 | $135.83 Million | $18.16 Million | 0.134x | -31.00% |
| 1999-12-31 | $46.41 Million | $8.99 Million | 0.194x | -- |
About Integer Holdings Corp
Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Puerto Rico, Costa Rica, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-v… Read more